A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes
Clinical trial NCT01849289 · COMPLETED
Trial details
- NCT number
- NCT01849289
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-02
- Primary completion
- 2014-05-15
- Enrollment
- 833
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.